BEC differentiation was adapted from Qian et al., 201717 (link). Human ESC/iPSC’s were disassociated to single cell via Accutase and reseeded at 35*103/cm2 onto matrigel coated plates in mTeSR1 supplemented with 10 μM Y27632 (Stem Cell Technologies). For the next two days, media was replaced with mTesR1 medium daily. On the third day, the medium as changed to DeSR1 medium (DMEM/F12 with Glutamax (Life Technologies) Supplemented with 0.1 mM B-mercaptoethanol, 1X MEM-NEAA, 1X penicillin-streptomycin and 6 μM CHIR99021 (R&D Systems). The following 5 days the medium was changed to DeSR2 (DMEM/F12 with Glutamax (Life Technologies) Supplemented with 0.1 mM B-mercaptoethanol, 1X MEM-NEAA, 1X penicillin-streptomycin and B-27 (Invitrogen)) and changed every day. After 5 days of DeSR2, the medium was changed to hECSR1 Human Endothelial SFM (ThermoFisher) supplemented with B-27, 10 μM retinoic acid and 20 ng/mL bFGF. The BEC’s were then split using Accutase and reseeded with hECSR1 supplemented with 10 μM Y27632. The BECs were then maintained through hECSR2 medium (hECSR1 medium lacking RA+bFGF).